The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...
This $4,626,921 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant was awarded on August 1, 2025 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization in Bethesda, Maryland. The research aims to elucidate the role of the...
This $2,402,721.00 Project Grant was awarded on April 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health, to be delivered by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). HJF is a non-profit organization that specializes in providing medical research, education, and training services...
The Department of Defense's Defense Health Agency awarded a $1,297,813 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This award, with a performance period from September 1, 2023 to August 31, 2027, aims to enhance functional restoration and accelerate return to duty following lower extremity autologous free-flap harvest procedures. As a global non-profit...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The Department of Defense's Defense Health Agency has awarded a $1,390,847 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support research to investigate the mechanistic role and therapeutic targeting of the cohesin RAD21 protein in metastatic prostate cancer. As a non-profit organization...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $488,086 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,460,695.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to support the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" research project. The award period runs from September 1, 2025 to August 31, 2028. The funded research aims to...
The Defense Health Agency awarded a $1,329,963 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) under the Military Medical Research and Development program (CFDA 12.420). The agreement supports a four-year study on transtibial osseointegration surgery, with a project period from September 30, 2023 to September 29, 2027. HJF, a nonprofit organization focused on accelerating progress in military medicine, has extensive experience...